Viatris Pharma GmbH

Viatris is a U.S.-based healthcare company dedicated to providing patients worldwide with easier access to medicines. We do this by promoting sustainable corporate governance, developing innovative solutions and making the best use of our skills to enable patients to achieve better treatment outcomes. Viatris was created in 2020 through the merger of Mylan and Pfizer PFE, a former Pfizer division specializing in branded products. The Viatris team brings together world-class expertise in science, manufacturing and distribution to ensure that patients receive the high-quality medicines they need, when and where they need them. In Switzerland, Viatris offers over 150 products and almost 1,000 galenic forms and packaging formats, including originals and branded generics. A wide range of therapeutic areas is covered by both prescription and over-the-counter preparations. Every year, 5 million boxes are distributed to patients. OUR MISSION Our mission is to enable people all over the world to live healthier lives at every stage of their lives. We act with courage, and our unique positioning is a source of stability in a world where healthcare needs are constantly evolving. Together with our partners, we create access and assume responsibility.